Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELASU PHARMACIE DES BANQUETS : revenue, balance sheet and financial ratios

SELASU PHARMACIE DES BANQUETS is a French company founded 21 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CAVAILLON (84300), this company of category PME shows in 2016 a revenue of 1.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELASU PHARMACIE DES BANQUETS (SIREN 478646821)
Indicator 2025 2016
Revenue N/C 1 562 482 €
Net income -33 476 € 83 320 €
EBITDA N/C 132 183 €
Net margin N/C 5.3%

Revenue and income statement

In 2025, SELASU PHARMACIE DES BANQUETS records a net loss of 33 k€. This deficit will reduce equity on the balance sheet.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-33 476 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 6%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 77%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

6.307%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

77.099%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

52.6%

Solvency indicators evolution
SELASU PHARMACIE DES BANQUETS

Sector positioning

Debt ratio
6.31 2025
2016
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Excellent -13 pts over 2 years

In 2025, the debt ratio of SELASU PHARMACIE DES BANQ... (6.31) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
77.1% 2025
2016
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Excellent +16 pts over 2 years

In 2025, the financial autonomy of SELASU PHARMACIE DES BANQ... (77.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
3.73 years 2016
2016
Q1: 2.17 years
Med: 6.32 years
Q3: 11.13 years
Good

In 2016, the repayment capacity of SELASU PHARMACIE DES BANQ... (3.73) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 243.43. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

243.432

Liquidity indicators evolution
SELASU PHARMACIE DES BANQUETS

Sector positioning

Liquidity ratio
243.43 2025
2016
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good +30 pts over 2 years

In 2025, the liquidity ratio of SELASU PHARMACIE DES BANQ... (243.43) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
13.4x 2016
2016
Q1: 4.69x
Med: 10.82x
Q3: 19.31x
Good

In 2016, the interest coverage of SELASU PHARMACIE DES BANQ... (13.4x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELASU PHARMACIE DES BANQUETS

Positioning of SELASU PHARMACIE DES BANQUETS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELASU PHARMACIE DES BANQUETS with other companies in the same sector:

Frequently asked questions about SELASU PHARMACIE DES BANQUETS

What is the revenue of SELASU PHARMACIE DES BANQUETS ?

The revenue of SELASU PHARMACIE DES BANQUETS in 2016 is 1.6 M€.

Is SELASU PHARMACIE DES BANQUETS profitable?

SELASU PHARMACIE DES BANQUETS recorded a net loss in 2025.

Where is the headquarters of SELASU PHARMACIE DES BANQUETS ?

The headquarters of SELASU PHARMACIE DES BANQUETS is located in CAVAILLON (84300), in the department Vaucluse.

Where to find the tax return of SELASU PHARMACIE DES BANQUETS ?

The tax return of SELASU PHARMACIE DES BANQUETS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELASU PHARMACIE DES BANQUETS operate?

SELASU PHARMACIE DES BANQUETS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.